Breast Cancer

<< Back

Headlines: (Click on headline for full article)

• Vitamin D influences racial differences in breast cancer risk.
  EurekAlert! Wed, 04 Apr 2012 16:23 PM
  American women of African ancestry are more likely than European Americans to have estrogen receptor (ER) negative breast cancer. New research published in BioMed Central's open access journal Breast Cancer Research has shown that specific genetic variations in the vitamin D receptor and in CYP24A1 (responsible for deactivating vitamin D) are associated with an increase in breast cancer risk ...
• NICE Fails to Grant Access to Innovative Treatment for Women With Advanced Breast Cancer, Despite Evidence That it Could Extend Their Lives
  HATFIELD, England, April 3, 2012 /PRNewswire/
  NICE concedes they must make corrections as toxicities were not reported appropriately for Halaven(R)Black Triangle Drug.
• Study finds some early breast cancer overdiagnosed
  ABC 6 Providence Mon, 02 Apr 2012
  For years, women have been urged to get screened for breast cancer because the earlier it's found, the better. Now researchers are reporting more evidence suggesting that's not always the case.
• Early Study Hints That Breast Cancer Vaccine Might Work Treatment aimed at stopping recurrence does trigger immune response, but true significance unknown
  By Kathleen Doheny HealthDay Reporter April 2, 2012  (HealthDay News)
  A vaccine to prevent breast cancer's return in women with a history of the disease has triggered the desired immune response in early research.
• Long-Term Estrogen Therapy Does Up Breast Cancer Risk: Study Data from government-funded study contradicts earlier findings on menopause treatment
  By Denise Mann HealthDay Reporter April 1 (HealthDay News)
  Several weeks after a study suggested that women who take estrogen-only hormone replacement to treat menopause symptoms may be at lower risk for developing breast cancer, another, much-larger study finds that when used for longer than 10 years, estrogen-only regimens actually raise a woman's long-term risk for breast cancer.
• Long-Term Estrogen Therapy Does Up Breast Cancer Risk: Study
  HealthDay Sun, 01 Apr 2012 16:08 PM PDT SUNDAY, April 1 (HealthDay News)
  Several weeks after a study suggested that women who take estrogen-only hormone replacement to treat menopause symptoms may be at lower risk for developing breast cancer, another, much-larger study finds that when used for longer than 10 years, estrogen-only regimens actually raise a woman's long-term risk for breast cancer.
• Estrogen-Only Therapy May Protect Against Breast Cancer, Research Suggests
  By Nicole Ostrow - Mar 7, 2012 5:00 AM GMT+0530
  Estrogen, a hormone known to fuel breast cancer, may protect against the disease in some cases, according to a study that found the therapy reduced the risk in women who took it after a hysterectomy.
• Gene work raises breast cancer hope
  Spalding Today Thu, 23 Feb 2012 16:19 PM PST
  The genetic code of the most common type of hereditary breast cancer has been mapped for the first time, raising hopes for better diagnosis and treatment for the killer disease, scientists have said.
• Breast conserving therapy versus mastectomy for stage I - II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial
  Lancet Sun, 26 Feb 2012 16:15 PM PST
  The EORTC 10801 trial compared breast-conserving therapy (BCT) with modified radical mastectomy (MRM) in patients with tumours 5 cm or smaller and axillary node negative or positive disease.
• New Breast Cancer Treatment Available in Italy
  wallstreet:online AG Wed, 25 Jan 2012 16:22 PM PST HATFIELD, England, January 26, 2012 /PRNewswire/
  Halaven(R) (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease, is now available under national reimbursement in Italy.
• Avastin may fight early breast cancers
  MSNBC Wed, 25 Jan 2012 16:15 PM PST
  Surprising results from two new studies may reopen debate about the value of Avastin for breast cancer. The drug helped make tumors disappear in certain women with early-stage disease, researchers found.
• Breast Cancer Before 50 Linked to More Distress
  HealthDay via Yahoo! News Fri, 20 Jan 2012 16:10 PM PST FRIDAY, Jan. 20 (HealthDay News)
  Younger women with breast cancer may experience a decrease in their health-related quality of life because of increased mental distress, weight gain and other factors, a new study finds.
• Doctor: Don’t Tell Your Kids You’re A Cancer Gene Carrier
  CBS Minnesota Fri, 20 Jan 2012 15:57 PM PST
   Women who have the breast cancer gene are 50 to 80 percent more likely to develop the disease. There's also a good chance they could pass the gene onto their children.
• Many Breast Cancer Patients Uninformed About Options: Study
  HealthDay via Yahoo! News Fri, 20 Jan 2012 16:10 PM PST
  FRIDAY, Jan. 20 (HealthDay News) -- In too many cases, doctors aren't doing a good job of informing American women with early stage breast cancer about the disease or their options in terms of surgery, a new study suggests.
• Drug Duo May Help Fight Aggressive Form of Breast Cancer Response rate increased with two-drug approach, researchers report
  By Kathleen Doheny HealthDay Reporter - TUESDAY, Jan. 17 (HealthDay News)
  Combining two drugs that target an aggressive type of breast cancer known as HER2-positive appears to work better than using either drug alone, researchers report.
• Does Deodorant Ingredient Affect Breast Cancer Risk? Small study finds suspect chemical even in women who never used the product, further muddying the debate
  By Kathleen Doheny HealthDay Reporter - THURSDAY, Jan. 12 (HealthDay News)
  For several years, researchers have studied a possible link between substances called parabens -- widely used as a germ-fighting preservative in cosmetics such as deodorant/antiperspirants -- and breast cancer.